Cargando…
Overactive bladder syndrome pharmacotherapy: future treatment options
Overactive bladder syndrome (OAB) is a lifestyle disease and its incidence increases with age. Although it is not a life-threatening disease, it is known to have a significant impact on the quality of life. The first-choice pharmacological treatment of OAB is antimuscarinics. However, their limited...
Autor principal: | Wróbel, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733900/ https://www.ncbi.nlm.nih.gov/pubmed/26848291 http://dx.doi.org/10.5114/pm.2015.56403 |
Ejemplares similares
-
Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014) -
Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021) -
NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
por: Xie, Xiang, et al.
Publicado: (2021) -
Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
por: Tran, Khanh, et al.
Publicado: (2009) -
Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life
por: Jayarajan, Jyotsna, et al.
Publicado: (2013)